Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USARAD is a leading teleradiology and telemedicine company that provides remote medical imaging interpretation services to healthcare facilities globally. The company operates a vast network of board-certified radiologists and specialists who deliver 24/7/365 coverage for various modalities, including MRI, CT, and X-ray. Through its subsidiary, SecondOpinions.com, USARAD also offers a direct-to-consumer platform for expert medical consultations and second opinions. In 2021, the company was acquired by Nano-X Imaging (Nanox) to integrate its radiology services with Nanox's digital X-ray technology and AI-driven diagnostic tools. This acquisition positions USARAD as a key component in the development of an end-to-end globally connected medical imaging solution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USARAD.